Re-exposure to blinatumomab after CD19-positive relapse: Experience from three trials in patients (pts) with relapsed/refractory B-precursor acute lymphoblastic leukemia (R/R ALL) Meeting Abstract


Authors: Topp, M. S.; Stelljes, M.; Zugmaier, G.; Barnette, P.; Heffner, L. T.; Trippett, T. M.; Bargou, R. C.; Holland, C.; Benjamin, J.; Litzow, M. R.
Abstract Title: Re-exposure to blinatumomab after CD19-positive relapse: Experience from three trials in patients (pts) with relapsed/refractory B-precursor acute lymphoblastic leukemia (R/R ALL)
Meeting Title: 2015 Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 33
Issue: 15 Suppl.
Meeting Dates: 2015 May 29-Jun 2
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2015-05-20
Language: English
ACCESSION: WOS:000358036901587
PROVIDER: wos
Notes: Meeting Abstract: 7051 -- Source: Wos